<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37259825</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-1402</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The European journal of general practice</Title><ISOAbbreviation>Eur J Gen Pract</ISOAbbreviation></Journal><ArticleTitle>Fear of COVID-19 among patients with prior SARS-CoV-2 infection: A cross-sectional study in Estonian family practices.</ArticleTitle><Pagination><StartPage>2195163</StartPage><MedlinePgn>2195163</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2195163</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/13814788.2023.2195163</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Fear of coronavirus disease (COVID-19) has been associated with significant health effects.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To assess COVID-19 fear and investigate factors associated with higher fear among COVID-19 survivors over 6 months after infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Cross-sectional study using multistage sampling (family practices within the highest 5th percentile of numbers of SARS-CoV-2 infected patients and random sample of patients within these practices) performed from March 15 to 17 July 2021. Adult patients with a laboratory-confirmed history of COVID-19 were recruited for a self-administered 79-item questionnaire including demographics, self-rated health, physical activity, COVID-19 characteristics, severity and the fear of COVID-19 Scale (FCV-19S). Comorbidity data were extracted from Estonian Health Insurance Fund. Logistic regression models were used to evaluate factors associated with COVID-19 fear.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 341 participants included, 60% were women, 24.2% were hospitalised due to COVID-19 and 22.2% had long COVID, 143 (42%) participants reported high levels of fear (cut-off FCV-19S &gt;17.8). Higher fear was associated with being female (aOR 2.12, 95% CI 1.14-3.95), age &#x2265;61&#x2009;years (aOR 3.23, 95% CI 1.28-8.16), two-member-households (aOR 3.70, 95% CI 1.40-9.77) physical inactivity 6 months prior to COVID-19 (aOR 3.53, 95% CI 1.26-9.95), and symptom severity during acute COVID-19. Long COVID was not associated with higher COVID-19 fear (aOR 1.82 95% CI 0.91-3.63).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Almost half of participants reported COVID-19 fear more than 6 months after infection. Greater fear was associated with sociodemographic factors, physical activity prior to COVID-19 and COVID-19 symptom severity. There is a need to target this population to develop appropriate interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soom&#xe4;gi</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3923-6750</Identifier><AffiliationInfo><Affiliation>Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meister</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4213-6657</Identifier><AffiliationInfo><Affiliation>Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vorobjov</LastName><ForeName>Sigrid</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0006-0248-6026</Identifier><AffiliationInfo><Affiliation>The National Institute of Health Development, Tallinn, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suija</LastName><ForeName>Kadri</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3364-7372</Identifier><AffiliationInfo><Affiliation>Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Continuing Education, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalda</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8434-0592</Identifier><AffiliationInfo><Affiliation>Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uusk&#xfc;la</LastName><ForeName>Anneli</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4036-3856</Identifier><AffiliationInfo><Affiliation>Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Gen Pract</MedlineTA><NlmUniqueID>9513566</NlmUniqueID><ISSNLinking>1381-4788</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000719188">Acrophobia</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004957" MajorTopicYN="N" Type="Geographic">Estonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005194" MajorTopicYN="N">Family Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005239" MajorTopicYN="N">Fear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 fear scale</Keyword><Keyword MajorTopicYN="N">FCV-19S</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">post covid</Keyword><Keyword MajorTopicYN="N">primary care</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37259825</ArticleId><ArticleId IdType="pmc">PMC10249452</ArticleId><ArticleId IdType="doi">10.1080/13814788.2023.2195163</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation . WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19 - 11 March 2020.  [Webpage]. 2020 [cited 2022 April 11]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19&#x2013;-11-march-2020.</Citation></Reference><Reference><Citation>Pan KY, Kok AAL, Eikelenboom M, et al. . The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry. 2021;8(2):121&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831806</ArticleId><ArticleId IdType="pubmed">33306975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorillo A, Gorwood P.. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. Eur Psychiatry. 2020;63(1):e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156565</ArticleId><ArticleId IdType="pubmed">32234102</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas G, Kiriaze IJ, Giannakis P, et al. . Psychosocial consequences of infectious diseases. Clin Microbiol Infect. 2009;15(8):743&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129378</ArticleId><ArticleId IdType="pubmed">19754730</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimoradi Z, Ohayon MM, Griffiths MD, et al. . Fear of COVID-19 and its association with mental health-related factors: systematic review and meta-analysis. BJ Psych Open. 2022;8(2):e73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943231</ArticleId><ArticleId IdType="pubmed">35307051</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper CA, Satchell LP, Fido D, et al. . Functional fear predicts public health compliance in the COVID-19 pandemic. Int J Ment Health Addict. 2021;19(5):1875&#x2013;1888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185265</ArticleId><ArticleId IdType="pubmed">32346359</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavazzoni F, Pancake R, Veronese G.. Impact of COVID-19 pandemic on mental health and quality of life. An exploratory study during the first outbreak in Italy. Psychol Rep. 2022:332941211066259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8914301</ArticleId><ArticleId IdType="pubmed">35271789</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen MM, Norekv&#xe5;l TM, Oterhals K, et al. . Psychometric properties of the norwegian version of the fear of COVID-19 scale. Int J Ment Health Addict. 2022;20(3):1446&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816751</ArticleId><ArticleId IdType="pubmed">33495690</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation . A clinical case definition of post COVID-19 condition by a Delphi consensus 2021. [updated 2021.  Oct 6]. WHO Reference Number: WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1. [cited 2022 April 11]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference><Reference><Citation>Open Knowledge Estonia.  Koroonakaart [Webpage]. [updated 2023.  Jan 31; cited 2023 Feb 3]. Available from: https://koroonakaart.ee/en.</Citation></Reference><Reference><Citation>Uusk&#xfc;la A, J&#xfc;rgenson T, Pisarev H, et al. . Long-term mortality following SARS-CoV-2 infection: a national cohort study from Estonia. Lancet Reg Health Eur. 2022;18:100394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9051903</ArticleId><ArticleId IdType="pubmed">35505834</ArticleId></ArticleIdList></Reference><Reference><Citation>Eesti Haigekassa.  Estonian health care system: Eesti Haigekassa; [cited 2023 January 28]. Available from: https://www.haigekassa.ee/en/people/health-care-services/estonian-health-care-system.</Citation></Reference><Reference><Citation>World Health Organisation.  Survey tool and guidance Copenhagen2020 [updated 29 July 2020]. WHO Reference Number: WHO/EURO:2020-696-40431-54222. [cited 2022 April 11]. Available from: https://www.who.int/europe/publications/i/item/WHO-EURO-2020-696-40431-54222.</Citation></Reference><Reference><Citation>Ahorsu DK, Lin CY, Imani V, et al. . The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2022;20(3):1537&#x2013;1545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100496</ArticleId><ArticleId IdType="pubmed">32226353</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Asthma Network.  Guidelines for the Translation of Questionnaires [Webpage]. [cited 2023 February 3]. Available from: http://globalasthmanetwork.org/surveillance/manual/translation.php.</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, et al. . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Li B, Couris CM, et al. . Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data From 6 countries. Am J Epidemiol. 2011;173(6):676&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu S, Tian S, Lou J, et al. . Clinical characteristics of older patients infected with COVID-19: a descriptive study. Arch Gerontol Geriatr. 2020;89:104058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194515</ArticleId><ArticleId IdType="pubmed">32339960</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean CP, Anderson ER.. Brave men and timid women? A review of the gender differences in fear and anxiety. Clin Psychol Rev. 2009;29(6):496&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">19541399</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomou I, Constantinidou F.. Prevalence and predictors of anxiety and depression symptoms during the COVID-19 pandemic and compliance with precautionary measures: age and sex matter. IJERPH. 2020;17(14):4924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400373</ArticleId><ArticleId IdType="pubmed">32650522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S, Seiffer B, Zeibig JM, et al. . Is physical activity associated with less depression and anxiety During the COVID-19 pandemic? A rapid systematic review. Sports Med. 2021;51(8):1771&#x2013;1783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060908</ArticleId><ArticleId IdType="pubmed">33886101</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirbas N, Kutlu R.. Effects of COVID-19 fear on society&#x2019;s quality of life. Int J Ment Health Addict. 2022;20(5):2813&#x2013;2822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443113</ArticleId><ArticleId IdType="pubmed">34539282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko&#xe7;ak O, Ko&#xe7;ak &#xd6;E, Younis MZ.. The psychological consequences of COVID-19 fear and the moderator effects of individuals&#x2019; underlying illness and witnessing infected friends and family. Int J Environ Res Public Health. 2021;18(4):1836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917729</ArticleId><ArticleId IdType="pubmed">33668655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens G, Gerritsen L, Duijndam S, et al. . Fear of the coronavirus (COVID-19): predictors in an online study conducted in March 2020. J Anxiety Disord. 2020;74:102258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286280</ArticleId><ArticleId IdType="pubmed">32569905</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo A, Gon&#xe7;alves N, Febra C.. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol. 2021;57:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920817</ArticleId><ArticleId IdType="pubmed">33662494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. . Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post&#x2013;COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikopoulou VA, Holeva V, Parlapani E, et al. . Mental Health Screening for COVID-19: a proposed cutoff score for the Greek version of the fear of COVID-19 scale (FCV-19S). Int J Ment Health Addict. 2022;20(2):907&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7654349</ArticleId><ArticleId IdType="pubmed">33199975</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto K, Hamatani S, Shimizu E, et al. . Impact of post-COVID conditions on mental health: a cross-sectional study in Japan and Sweden. BMC Psychiatry. 2022;22(1):237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8977559</ArticleId><ArticleId IdType="pubmed">35379224</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo F, Ghanei Gheshlagh R, Dalvand S, et al. . Systematic review and meta-analysis of fear of COVID-19. Front Psychol. 2021;12:661078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8231929</ArticleId><ArticleId IdType="pubmed">34177712</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimoradi Z, Lin CY, Ullah I, et al. . Item response theory analysis of the fear of COVID-19 scale (FCV-19S): a systematic review. PRBM. 2022;ume 15:581&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8922366</ArticleId><ArticleId IdType="pubmed">35300204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CY, Hou WL, Mamun MA, et al. . Fear of COVID-19 scale (FCV-19S) across countries: measurement invariance issues. Nurs Open. 2021;8(4):1892&#x2013;1908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186712</ArticleId><ArticleId IdType="pubmed">33745219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba&#x107;ak V, &#xd3;lafsd&#xf3;ttir S.. Gender and validity of self-rated health in nineteen European countries. Scand J Public Health. 2017;45(6):647&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">28673121</ArticleId></ArticleIdList></Reference><Reference><Citation>Olthuis JV, Watt MC, Bailey K, et al. . Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016;3(3):Cd011565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7077612</ArticleId><ArticleId IdType="pubmed">26968204</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>